DNA Extraction, Isolation, Purification Market Report | Global Outlook 2022-2030

The DNA Extraction, Isolation, and Purification market was valued at US$ 3,096.54 million in 2022 and is projected to reach US$ 6,107.92 million by 2030. It is estimated to register a CAGR of 8.9% during 2022–2030.

Market Insights and Analyst View:

DNA extraction is the first stage of the DNA purification process. The DNA can be extracted from proteins, cell membranes, and other cellular components using physical and/or chemical methods. Commercially available kits, offered with instruction manuals, are used for DNA extraction in laboratories wherein DNA is extracted daily. Various tissues can be used for DNA extraction including blood, body fluids, frozen tissue section, formalin-fixed paraffin-embedded tissues.

DNA extraction plays an irreplaceable role in molecular biology as it is essential for various downstream biological analyses. Thus, the reliability and accuracy of downstream research outcomes depend on upstream DNA extraction methodology. Silica or magnetic are the most innovative DNA extraction techniques that are used for DNA extraction and purification. Moreover, new technologies are being introduced and validated to expand the capabilities of laboratories reliant on DNA-based analyses with improved sensitivity and information outcomes. Forensic laboratories use automation for sample preparation and data interpretation to meet increasing throughput demands. The DNA results are widely used to study diseases and drug responses at the genetic level. The errors generated by the degradation of DNA have a quantitative and qualitative effect on results. The reduction in the size of the DNA may impact downstream applications such as hybridization assays and PCR. The demand for DNA extraction is continuously growing due to the emerging applications of extracted and purified DNA, and rising R&D in genomics.

Growth Drivers and Challenges:

DNA extraction techniques used to isolate DNA from biological samples play a pivotal role in biotechnology applications, ranging from fundamental research to routine diagnostic and therapeutic decision-making. The extracted, isolated, and purified DNA can be used to study the genetic causes and management of various diseases. DNA extraction, isolation, and purification procedures are commonly used in forensic science studies, genome sequencing, spotting environmental bacteria and viruses, and establishing paternity. Furthermore, ancestry tracking, medical tests, genetic engineering, etc., are a few more application areas of the DNA extraction procedures. Genomics holds significant potential for improved diagnostics and treatment of genetic diseases. Genomic DNA extraction is one of the most common procedures in the life sciences. Genomic DNA contains all of an organism's genetic and chromosomal material and encodes all of the components required for life. The emergence of cutting-edge technologies for sequencing and assembly, and analysis of sequenced data is likely to strengthen the importance of genomics in medicine and other branches of science. Thus, government and non-government agencies are taking initiatives to boost genomic research. The Genomics Research and Development Initiative (GRDI) receives ~US$ 20 million from the Government of Canada (GC) annually to carry out research on vital topics in genomics.

Cost is a major factor that influences the selection of any product. The cost of DNA extraction, isolation, and purification kits and instruments are relatively high, which prohibits the regular use of these products. For instance, the Promega Wizard Genomic DNA Purification Kit costs ~US$ 324.45. Since the cost of consumables and instruments is high, institutes working with these products must appoint highly skilled staff to avoid wastage. Also, several consumables and reagents need to be used with serial dilutions as they are required in low concentrations, which can be a tedious job. This further requires more effort and resources to conduct a stringent recruitment process. Thus, the high-cost processes and the need for highly skilled workforces hampers the growth of the DNA extraction, isolation, and purification market

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

DNA Extraction, Isolation, and Purification Market: Strategic Insights

DNA Extraction, Isolation, and Purification Market

• 
  CAGR (2022 - 2030)

  8.9%
• Market Size 2022
  US$ 3.1 Billion
• Market Size 2030
  US$ 6.11 Billion

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Key Players

• Bio-Rad Laboratories Inc
• DH Life Sciences LLC
• GE HealthCare Technologies Inc
• F. Hoffmann-La Roche Ltd
• Agilent Technologies Inc
• Qiagen NV
• Merck KGaA
• Illumina Inc
• Takara Bio Inc
• Thermo Fisher Scientific Inc

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Type

• Kits
• Instruments
• Reagents

Method

• Chemical Method and Physical Method

Sample Type

• Blood
• Body Fluids
• Others

Source

• Genomic DNA and Microbial DNA

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Report Segmentation and Scope:

The DNA extraction, isolation, and purification market is segmented on the basis of type, method, source, sample type, application, and end user. By type, the market is segmented into kits, instruments, and reagents. The DNA extraction, isolation, and purification market, by sample type, is segmented into blood, body fluids, and others. In terms of method, the DNA extraction, isolation, and purification market is bifurcated into chemical methods and physical methods. Based on source, the DNA extraction, isolation, and purification market, is divided into genomic DNA, and microbial DNA. Based on application, the market is segmented into PCR tests, next-generation sequencing (NGS), microarrays, and others. Based on application, the market is segmented into hospitals, diagnostic centers and research laboratories, pharmaceutical and biopharmaceutical companies, CROs, and others. The DNA extraction, isolation, and purification market, based on geography, is segmented into North America (US, Canada, and Mexico), Europe (France, Germany, Italy, UK, Spain, Benelux, Austria, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, Malaysia, Indonesia, and Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, Rest of South & Central America)

Segmental Analysis:

By type, the DNA extraction, isolation, and purification market is segmented into kits, instruments, and reagents. In 2022, the kits segment held the largest share of the market. Moreover, the market for this segment is expected to grow at the fastest CAGR during 2022–2030. DNA extraction kits make it easy to separate high-molecular-weight DNA from tissues, whole blood, and cultured cells. An increase in the number of patients with various chronic diseases boosts the demand for molecular diagnostic tests, which creates the need for efficient DNA extraction kits.

DNA Extraction, Isolation, and Purification Market, by Type – 2022 and 2030

Access Data

Based on the method, the DNA extraction, isolation, and purification market is bifurcated into chemical methods and physical methods. The chemical methods segment held a larger market share in 2022, and it is anticipated to register a higher CAGR during 2022–2030. Chemical methods of DNA extraction, isolation, and purification are categorized as phenol-chloroform methods, silica gel method, proteinase K method, and others. Various organic or inorganic chemicals, including phenol, chloroform, cationic cetyltrimethylammonium bromide (CTAB), non-ionic (Triton X-100), sodium dodecyl sulfate (SDS), isoamyl alcohol, tris, and ethylenediaminetetraacetic acid (EDTA), are widely used in chemical-based DNA extraction, isolation, and purification. A chemical method is widely used for DNA extraction due to advantages such as high purity of extracted DNA and lower cost of an extraction process.

The DNA extraction, isolation, and purification market, by sample type, is divided into blood, body fluids, and others. In 2022, the blood segment held the largest market share. The other segment is anticipated to register the highest CAGR in the DNA extraction, isolation, and purification market during 2022–2030. In humans, whole blood is the primary source of DNA for genotype-related research. A method for isolating genomic DNA from whole blood is quick, efficient, and cost-effective. However, limitations related to transportation, storage, etc., hinder its use in DNA extraction and purification.

By source, the DNA extraction, isolation, and purification market is bifurcated into genomic DNA and microbial DNA. In 2022, the genomic DNA segment held a larger share of the market and is anticipated to register the highest CAGR during 2022–2030. Genomic DNA can be obtained from blood and biological fluids, tissues and cells, forensic samples, plants and fungi, and food samples. The commercially available genomic DNA extraction kits aid in the magnification of yield with the improved quality of the extracted DNA. Additionally, these kits help rapid and efficient isolation of genomic DNA. GeneJET Genomic DNA Purification Kit, Maxwell RSC Genomic DNA Kit, etc., are a few of the examples of commercially available products for the extraction and purification of genomic DNA.

The DNA extraction, isolation, and purification market, based on application, is segmented into PCR tests, next-generation sequencing (NGS), microarray, and others. In 2022, the next-generation sequencing (NGS) segment held the largest market share. The market for NGS is anticipated to grow at the highest CAGR during 2022–2030. Next-generation sequencing (NGS) is one of the recent developments in DNA variant/mutation detection techniques. It combines the benefits of distinctive sequencing chemistries, various sequencing matrices, and bioinformatics technology. This technique has made the parallel sequencing of DNA sequences of different lengths, or the entire genome, possible in a reasonably short time. NGS is widely used in applications that facilitate therapeutic decisions, prognoses, disease diagnoses, etc. 

Based on end user, the DNA extraction, isolation, and purification market is divided into hospital diagnostic centers and research laboratories, pharmaceutical and biopharmaceutical companies, CROs, and others. The hospital diagnostic centers and research laboratories segment held the largest share of the market in 2022. The same segment is anticipated to register the highest CAGR in the market during 2022–2030. Hospital diagnostic centers and research laboratories engage in the diagnosis of various diseases on a daily basis. They also initiate or participate in various research projects to develop novel technologies and products. DNA extraction, isolation, and purification techniques have vast clinical applications in studies focusing on enhancing the diagnosis and treatment capabilities of chronic diseases. They hold huge potential for gene discovery and rare genetic disorder diagnoses.

Regional Analysis:

Based on geography, the DNA extraction, isolation, and purification market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. The market in North America has been analyzed with a prime focus on three major countries—the US, Canada, and Mexico. North America held the largest share of the DNA extraction, isolation, and purification market in 2022. The growing demand for advanced diagnostic tools in molecular genetics and cytogenetics, and the rising prevalence of genetic disorders and cancer fuel the market growth in this region. Data published by the American Cancer Society states that the US recorded ~1.9 million new cancer cases and 609,360 cancer-related deaths in 2022. Moreover, according to the Canadian Cancer Society 2022, ~30,000 Canadians suffered from lung or bronchus cancer in 2022, accounting for 13% of all new cancer cases. Therefore, demand for DNA extraction is increasing since the extracted material is used to identify chromosomal abnormalities to diagnose various types of cancer. These systems enable healthcare professionals to detect genetic anomalies early, allowing for more targeted and effective treatment strategies.

DNA Extraction, Isolation, and Purification Market Opportunity:

New Product Launches and Approvals

The biotechnology industry is developing significantly due to the increasing demand for technologically advanced products. This, in turn, results in a rise in the number of new product developments, launches, and approvals. Additionally, major market players engage in R&D activities to ensure the innovation and development of efficient products. A few of the recent product launches and developments in the DNA extraction, isolation, and purification market are mentioned below.

CD Bioparticles is a leading manufacturer and supplier of products in application areas such as in-vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassays. In August 2023, the company announced the launch of its new line of DNA extraction and purification kits made for the quick and accurate isolation of DNA, including cell-free DNA (cfDNA), genomic DNA, plasmid DNA, tissue DNA, mitochondrial DNA, and PCR yields.

In March 2023, BioEcho Life Sciences announced the launch of the EchoLUTION FFPE DNA Kit that offers an innovative way to extract DNA from Formalin-Fixed Paraffin-Embedded (FFPE) samples.

In April 2022, Purigen Biosystems, Inc., one of the leading providers of next-generation technologies, announced the launch of Ionic Cells to Pure DNA Kit. The kit has been optimized to allow the users of Ionic Purification Systems to extract higher-quality DNA from white blood cells (WBCs), peripheral blood mononuclear cells (PBMCs), and cultured or sorted cells.

Thus, an increase in product developments and launches is likely to create ample opportunities for the growth of the DNA extraction, isolation, and purification market in the coming years.  

Competitive Landscape and Key Companies:

A few of the prominent players operating in the global DNA extraction, isolation, and purification market are Bio-Rad Laboratories Inc, DH Life Sciences LLC, GE HealthCare Technologies Inc, F. Hoffmann-La Roche Ltd, Agilent Technologies Inc, Qiagen NV, Merck KGaA, Illumina Inc, Takara Bio Inc, Thermo Fisher Scientific Inc, and Molzym GmbH & Co KG. These companies focus on the development of new technologies, advancements in existing products, and expansion of geographic footprint to meet the growing consumer demand worldwide and expand their product range in specialty portfolios. Companies in the global DNA extraction, isolation, and purification market are implementing various inorganic and organic developments. A few of the instances are mentioned below:

In June 2023, QIAGEN launched of the QIAseq Normalizer Kits, providing researchers a fast, convenient and cost-effective method to pool different DNA libraries for best-quality results from next-generation sequencing (NGS) runs.

In December 2022, therascreen KRAS RGQ PCR kit (therascreen KRAS kit) was approved by the US Food and Drug Administration (FDA) as a companion diagnostic test to Mirati Therapeutic’s KRAZATI (adagrasib) drug against non-small cell lung cancer (NSCLC).

DNA Extraction, Isolation, and Purification Market Report Scope